Parameter
| Biomarker | MEG3 | Full name | Maternally expressed gene 3 (long non-coding RNA) | Molecular Type | Long chain non-coding RNA (lncRNA) |
|---|---|---|---|---|---|
| Molecular Formula | Macromolecule | Molecular Weight | / | Core Functional Dimensions | Diagnosis and Prognosis |
| Disease | Pituitary Adenoma | Disease Subtypes | / | ||
| Organ | Pituitary | Test Sample / Technology Platform | Organization/serum (RT - qPCR) | ||
| Pathobiological Mechanisms | Tumor suppressor genes, through the p53 pathway inhibition of tumor | ||||
| Clinical Availability Status | Clinical validation: NFPA by methylation in silence, to express strong hint invasive | ||||
| Notes and Dynamics | Serum MEG3 detection is expected to become a noninvasive markers | ||||